The founder of Roivant Sciences will step down from the role of chief executive officer, the SoftBank-backed biotechnology company said on Monday.
Chief Financial Officer Matt Gline will replace Vivek Ramaswamy, who will step into the role of executive chairman.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,